Key Considerations for the Lenvatinib-Pembrolizumab-Chemotherapy Regimen in Advanced Gastric Cancer: Insights From LEAP-015.
APA
Jiang Z, Xiang Y, Yi B (2026). Key Considerations for the Lenvatinib-Pembrolizumab-Chemotherapy Regimen in Advanced Gastric Cancer: Insights From LEAP-015.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 44(4), 345-346. https://doi.org/10.1200/JCO-25-02049
MLA
Jiang Z, et al.. "Key Considerations for the Lenvatinib-Pembrolizumab-Chemotherapy Regimen in Advanced Gastric Cancer: Insights From LEAP-015.." Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 44, no. 4, 2026, pp. 345-346.
PMID
41380117
같은 제1저자의 인용 많은 논문 (5)
- Deep learning-based mismatch repair prediction using colorectal cancer macroscopic images: a diagnostic study.
- Comment on "Agile 3 + and 4 Scores Accurately Predict Major Adverse Liver Outcomes, Liver Transplant, Progression of MELD Score, the Development of Hepatocellular Carcinoma, and Death in NAFLD".
- Using F-FDG PET/CT-derived body composition features to predict lymphovascular invasion in non-small cell lung cancer.
- Single-cell profiling reveals lineage-specific fibroblast stromal subtypes drive ECM remodeling and immune modulation in the hepatocellular carcinoma tumor microenvironment.
- [Ga]-FAPI-04 outperforms [F]-FDG in gastric cancer staging: a comparative study using PET/CT and PET/MR.